Moreover, in AdSqLCs, a relatively high frequency of EGFR mutations (mut-EGFR) is described [9,10], thereby patients with AdSqLCs are treated as lung adenocarcinoma. The gene discussed is EGFR; the disease is lung adenocarcinoma.